I agree that this site is using cookies. You can find further informations here.
X
Camus, V
701  results:
Search for persons X
?
1

Prognostic value of the combination of volume, massiveness ..:

Draye-Carbonnier, S. ; Camus, V. ; Becker, S....
Scientific Reports.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

Exploring the structure and electronic properties of indivi..:

Navarro-Rodriguez, M. ; Camús, V. ; Cros, A....
Applied Surface Science.  642 (2024)  - p. 158611 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Impact of intermittent versus continuous infusions on centr..:

MacPhail, A. ; Nguyen, A. ; Camus, V....
Journal of Hospital Infection.  151 (2024)  - p. 21-28 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Valeur pronostique de la combinaison des paramètres de volu..:

Draye Carbonnier, S. ; Camus, V. ; Becker, S....
Médecine Nucléaire.  48 (2024)  2 - p. 83 , 2024
Link: https://doi.org/10.1016/..
 
?
5

ROMIDEPSIN PLUS CHOP VERSUS CHOP IN PATIENTS WITH PREVIOUSL..:

Camus, V. ; Thieblemont, C. ; Gaulard, P....
Hematological Oncology.  41 (2023)  S2 - p. 77-78 , 2023
Link: https://doi.org/10.1002/..
 
?
6

Treatment with anti CD19 CAR‐T cells is safe and effective ..:

Marieton, E. Robin ; Le Bras, F. ; Malfuson, J....
Hematological Oncology.  41 (2023)  S2 - p. 456-457 , 2023
Link: https://doi.org/10.1002/..
 
?
7

COMBINING BASELINE TOTAL METABOLIC TUMOR VOLUME AND BETA‐2‐..:

Zduniak, A. ; Lévêque, E. ; Draye‐Carbonnier, S....
Hematological Oncology.  41 (2023)  S2 - p. 670-671 , 2023
Link: https://doi.org/10.1002/..
 
?
8

MOLECULAR CHARACTERIZATION CONTRIBUTES TO DIAGNOSIS AND PRE..:

Camus, V. ; Viailly, P. ; Sesques, P....
Hematological Oncology.  41 (2023)  S2 - p. 110-111 , 2023
Link: https://doi.org/10.1002/..
 
?
9

P1217: INTRATHECAL METHOTREXATE PROPHYLAXIS AND CENTRAL NER..:

Renaud, L. ; Stéphan, P. ; durand, S....
HemaSphere.  6 (2022)  - p. 1103-1104 , 2022
Link: https://doi.org/10.1097/..
 
?
10

P1186: A LARGE FRENCH REAL WORLD MULTICENTRIC PROSPECTIVE C..:

Ghesquieres, H. ; Cherblanc, F. ; Belot, A....
HemaSphere.  6 (2022)  - p. 1072-1073 , 2022
Link: https://doi.org/10.1097/..
 
?
11

OUTCOMES AFTER FIRST‐LINE IMMUNOCHEMOTHERAPY FOR PRIMARY ME..:

Camus, V. ; Rossi, C. ; Sesques, P....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
12

Cognitive impairments in treatment-resistant depression: Re..:

Vancappel, A ; Dansou, Y ; Godin, O...
Journal of Affective Disorders Reports.  6 (2021)  - p. 100272 , 2021
Link: https://doi.org/10.1016/..
 
?
13

LONG‐TERM OUTCOMES OF ELDERLY PATIENTS TREATED WITH FRONTLI..:

Camus, V. ; Belot, Aurél. ; Oberic, L....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
14

RITUXIMAB PLUS GEMCITABINE AND OXALIPLATIN (R‐GemOx) IN REF..:

Cazelles, C. ; Belhadj, K. ; Vellemans, H....
Hematological Oncology.  37 (2019)  S2 - p. 429-429 , 2019
Link: https://doi.org/10.1002/..
 
?
15

TARGETED GENOTYPING OF CIRCULATING TUMOR DNA FOR CLASSICAL ..:

Camus, V. ; Viennot, M. ; Viailly, P....
Hematological Oncology.  37 (2019)  S2 - p. 187-188 , 2019
Link: https://doi.org/10.1002/..
 
1-15